SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001047469-20-002367
Filing Date
2020-04-16
Accepted
2020-04-16 17:19:48
Documents
9
Period of Report
2020-04-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2241390z8-k.htm 8-K 25074
2 EX-4.1 a2241390zex-4_1.htm EX-4.1 128709
3 EX-4.2 a2241390zex-4_2.htm EX-4.2 127558
4 EX-5.1 a2241390zex-5_1.htm EX-5.1 12451
5 EX-10.1 a2241390zex-10_1.htm EX-10.1 237030
6 EX-99.1 a2241390zex-99_1.htm EX-99.1 11926
7 G159945KOI001.GIF g159945koi001.gif GRAPHIC 2485
8 G159945KOI002.GIF g159945koi002.gif GRAPHIC 3319
9 G159945MMI001.JPG g159945mmi001.jpg GRAPHIC 5210
  Complete submission text file 0001047469-20-002367.txt   559744
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 20797144
SIC: 3841 Surgical & Medical Instruments & Apparatus